Design Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
DSGN
CUSIP
25056L103
Type
Equity
Class
COM
Num filers
102
Total reported value, excl. options
$172M
Manager Report Date Value ($000) Shares Option Type